GSTM1 and inflammatory bowel disease: While the analysis revealed that all three IV iron formulations had better hemoglobin response than oral iron, there was no statistically significant difference between the FDI, FCM, and IS with respect to the percentage of IBD patients showing normalization of Hb or increase in Hb of ≥2 g/dL.